Projected Earnings Date: 2025-01-28    (Delayed quote data   2025-01-03)
Last
 104.47
Change
 ⇑ +0.01   (+0.01%)
Volume
  1,202,941
Open
 104.52
High
 104.60
Low
 102.98
8EMA (Daily)
 105.67
40EMA (Daily)
 107.46
50EMA (Daily)
 107.60
STO (Daily)
 18.956
MACD Hist (Daily)
 -0.557
8EMA (Weekly)
 107.124
40EMA (Weekly)
 110.97
50EMA (Weekly)
 112.16
STO (Weekly)
 37.771
MACD Hist (Weekly)
 0.110
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com